Labetalol Hcl Injection
Product Images NDC 51662-1602

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Labetalol Hcl (NDC 51662-1602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Labeling (51662 1602 1 Serialized Box Labeling)

Box packaging of Labetalol HCl Injection USP, 100 mg/20 mL (5 mg/mL) intravenous injection, labeled for multiple dose vial use. The label shows it is for intravenous injection only, sterile, and distributed by HF Acquisition Co LLC under the West-Ward brand.*

FDA Label Image

Adverse (Adverse)

A data table showing the incidence of various side effects by daily dose of Labetalol HCl in mg. Columns represent doses ranging from 200 to 2400 mg and rows list side effects such as dizziness, fatigue, nausea, vomiting, dyspepsia, paresthesia, nasal stuffiness, ejaculation failure, impotence, and edema. The table includes patient numbers per dose and percentage or counts for each side effect.*

FDA Label Image

Box Labeling (Box Labeling)

Label for Labetalol HCl Injection USP, 100 mg/20 mL (5 mg/mL), for intravenous injection only. The label indicates a 20 mL multiple dose vial, distributed by West-Ward, with manufacturing by Hikma Farmacêutica in Portugal. The label includes dosage, storage instructions, and preservative information.*

FDA Label Image

Dosage (Dosage)

A data table titled 'Inpatient Titration Instructions' showing dosage regimens and corresponding daily doses. The regimen column lists 200 mg b.i.d., 400 mg b.i.d., 800 mg b.i.d., and 1,200 mg b.i.d. The daily dose column shows 400 mg, 800 mg, 1,600 mg, and 2,400 mg respectively. A footnote indicates the total daily dose may be divided into three doses if needed.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of LABETALOL HCl showing the molecular arrangement including aromatic rings, hydroxyl, amine, and amide groups, with a separate hydrochloride (HCl) indicated.*

FDA Label Image

Vial Label (Vial Label)

Label for Labetalol HCl Injection, USP, 5 mg/mL (100 mg/20 mL) in a 20 mL multiple dose vial for intravenous injection. The label shows dosage information, storage instructions including protection from light and refrigeration, and indicates it is manufactured by HF Acquisition Co LLC, DBA HealthFirst.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.